Home
Galenika

Galenika Market Share Analysis for July 2026

Generičko ime (INN): sulfametoksazol; trimetoprim

Health > Health - Other

Domaingalenika.rs

Year Founded1945

Employees501 - 1000

Annual Revenue$100M - $200M

Galenika

Galenika (including company regionals)

galenika.rs

See more website traffic and engagement information

Galenika Revenue up to July 2026 is 100M - 200M

revenue generated by Galenika top domains

Galenika top domains revenue over 3 years

Revenue for Galenika top domains

galenika.rs100M - 200M

See more with Sales Intelligence

Total visits to Galenika's top domains

Understand Galenika market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

galenika.rs42.1K

See more with Sales Intelligence

Avg. visit duration in Galenika's top domains

Analyze Galenika engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

galenika.rs00:00:43

See more with Sales Intelligence

Avg. pageviews on Galenika's top domains

See how Galenika keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

galenika.rs1.97

See more with Sales Intelligence

Galenika top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Galenika

These are the website technologies, by industry, used by Galenika top domains

Widget (9)

Twemoji

Advertising (8)

Google Adsense

Conversion & Analytics (5)

Google Analytics

Social (4)

Instagram

More Technologies

11

See all

News & Signals from Galenika

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGalenika launched peptide-based platform on Jan 1st '25.In the year of its 80th anniversary, Galenika has announced a major market innovation: a peptide-based platform developed in collaboration with its sister company EMS in Brazil.

NewsGalenika recognized as innovation leader.- Ekapija is proud that the pharmaceutical company Galenika was recognized as an innovation leader by the Association of Inventors of Belgrade - the organization which awarded Ekapija for the contribution to the development and popularization of innovations and innovative activities in the country and the world.

NewsGalenika launches study on the daily habits and healthy lifestyle of students.Galenika has launched a study on the daily habits and healthy lifestyle of students, according to which almost two thirds of students believe that a healthy diet is very important.